Seeing Is Believing
NVCT is currently covered by 1 analysts with an average price target of $9.05. This is a potential upside of $2.71 (42.74%) from yesterday's end of day stock price of $6.34.
Nuvectis Pharma's activity chart (see below) currently has 5 price targets and 10 ratings on display. The stock rating distribution of NVCT is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 10% with an average time for these price targets to be met of 65 days.
Highest price target for NVCT is $10, Lowest price target is $10, average price target is $10.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 04-Aug-2025. First documented stock forecast 02-Mar-2022.
Currently out of the existing stock ratings of NVCT, 6 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$10
$3.57 (55.52%)
$15
17 days ago
(04-Aug-2025)
1/10 (10%)
$2.71 (37.17%)
65
What is NVCT (Nuvectis Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on NVCT (Nuvectis Pharma) with a proven track record?
Which analyst has the most public recommendations on NVCT (Nuvectis Pharma)?
Which analyst is the currently most bullish on NVCT (Nuvectis Pharma)?